IB
Iovance Biotherapeutics Inc
🇺🇸XNAS.IOVAUnited StatesHealthcare
$9.76USDup +0.38 (+4.05%)OpenDelayed4:20 PM
Price$9.76+0.38 (+4.05%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4622601007
- CUSIP
- 37182R102
Company
- Employees
- 975
- Headquarters
- San Carlos, United States
- Website
- https://www.iovance.com
- CEO
- Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Market
- Shares outstanding
- 453M
- Market cap
- $4.42B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $4.25B
- EPS LTM
- -$0.64calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -15.27calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $324.97M+34.55%up year on year
- Net income
- -$289.52M+25.75%up year on year
- Gross margin
- 116.3%+464.57%up year on year
- Free cash flow
- -$296.4M+8.39%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.